Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical Trials
TORONTO & LAUSANNE, Switzerland & NEW YORK–(BUSINESS WIRE)–Altis Labs, Inc. (“Altis”), the computational imaging company accelerating clinical trials with artificial…